Wnt/FGF20 signaling axis promotes migration of proximal blastema cell during tail regeneration of Gekko japonicus Authors: Man Xu, Zhen Li, Jing Yu, Mingxuan Li, Yufang Zhang, Shuai Huang, Yanran Xu, Xu Chen, Ronghua Wu, Mei Liu, Yan Liu Published: 2025 ABSTRACT AbstractThe Wnt/FGF20 axis establishes an organizing center that is largely non-proliferative in the distal blastema during epimorphic regeneration across multiple model systems. However, the underlying mechanisms remain poorly characterized. In this study, we investigate the role of the Wnt/FGF20 axis during tail regeneration in Gekko japonicus. We also developed an in vitro system to evaluate the effects of Wnt agonists, FGF20, and FGFR4 on cultured blastema cells. Our results demonstrate that Wnt signaling is activated in distal blastema cells and contributes to a lower proportion of proliferative cells beneath the epidermal basal layer in the regenerating tail of Gekko japonicus. This Wnt-mediated suppression of proliferation is associated with reduced FGFR4 expression, as confirmed both in vitro and in vivo. Furthermore, Wnt pathway activation upregulates FGF20 expression in distal blastema cells, which promotes the migration of proximal blastema cells without affecting their proliferation. Our findings provide an insight into the organizing center of regenerated tissue, revealing a reciprocal regulatory interaction between the epidermis and blastema cells during successful epimorphic regeneration.Subject terms: Cell biology, Zoology Introduction Regeneration, a widespread phenomenon among animals, facilitates the restoration of lost body parts following injury or amputation. The regenerative capacity of tissues varies considerably across species. While mammals exhibit limited regenerative abilities, with only a few tissues capable of regeneration, some non-mammalian vertebrates demonstrate remarkable tissue and organ regenerative potential1–4. For instance, zebrafish regenerate their heart and fins5–7, salamanders can regenerate limbs8, and lizards are capable of tail regeneration9,10. A key characteristic across these regenerative models is the formation of the wound epithelium (WE). Following autotomy or amputation, epithelial cells migrate to the wound site, forming the WE, which is essential for initiating regeneration. This epidermis thickens and secretes numerous diffusible signaling factors that influence the growth of the underlying mesenchyme11,12. The dynamic interaction between the WE and the blastema is critical for the restoration of lost appendages2 and the regeneration process differs significantly in complexity and underlying mechanisms13. Signaling networks involved in regenerative processes have been extensively characterized. Signaling centers, which are pivotal for appendage regeneration, express mitogenic, chemotactic, and inductive signals that regulate cell proliferation, migration, and fate determination of surrounding cells2,14,15. Among regenerating vertebrates, the Wnt/β-catenin and FGF signaling pathways are integral to the formation of both the WE and the blastema16–21. In zebrafish caudal fin regeneration, Wnt/β-catenin defines organizing centers that govern regeneration growth, differentiation, and patterning by producing secreted factors that influence surrounding tissues22. Our previous study similarly demonstrated the necessity of Wnt/β-catenin signaling in tail regeneration in Gekko japonicus23,24. Additionally, Wnt/β-catenin-regulated FGFs are key modulators of epidermal and mesenchymal cell behaviors19,25. In epimorphic regeneration models, Fgf20 and Fgf3 are well-established Fgf ligands in the WE and blastema26. Fgf20, initially identified as a critical factor in initiating zebrafish fin regeneration27, is primarily expressed in the most distal mesenchymal tissue of regenerating structures. Furthermore, FGF20 has been shown to be required for the regeneration of axial tissues in Xenopus tadpole tails, but it does not play a role in epidermal tissue healing and regeneration28. In contrast, Chen et al. demonstrated that Fgf20 induces transient expression of laminin beta 1a, which defines the WE during zebrafish fin regeneration29. Therefore, the precise role of FGF20 in initiating regeneration, as well as the coordination between Wnt and FGF20 signaling in the WE and mesenchymal blastema, warrants further investigation. This study explores the impact of the Wnt/FGF20 axis on tail regeneration in Gekko japonicus. Our findings indicate that Wnt signaling is activated in the distal blastema cells, which exhibit a low proliferative capacity, similar to the blastema of regenerating zebrafish fins. Additionally, these cells produce FGF20 in response to Wnt signaling, with FGF20 promoting the migration of proximal blastema cells, although it does not influence their proliferation. This study offers insights into the reciprocal interactions between the epidermis and blastema cells, contributing to a deeper understanding of the mechanisms underlying epimorphic regeneration. Results Wnt/β-catenin signaling is activated in distal lower proliferative blastema during tail regeneration of Gekko japonicus Wnt/β-catenin signaling plays a central role in regulating cell proliferation and cell fate across various regeneration models. During the regeneration of zebrafish fin and lizard tail, the distal-most blastemal domain is largely non-proliferative30–33, with Wnt/β-catenin signaling being notably active in this non-proliferative region22. The process of tail regeneration and the associated signaling pathways in geckos closely resemble those involved in zebrafish caudal fin regeneration. Based on this similarity, it is hypothesized that a comparable population of non-proliferative cells in the distal blastema of regenerating gecko tails may exhibit activated Wnt/β-catenin signaling. To explore the spatial distribution of proliferating blastema cells during tail regeneration, we administered 25 μl of 10 mM EdU diluted in phosphate-buffered saline (PBS) via intraperitoneal injection for two consecutive days prior to sample collection (Fig. 1a). EdU labeling assays were performed at different time points (Fig. 1a-e’). We analyzed the percentage of EdU-negative blastema cells in every 50 µm zones from the distal-most end to the proximal side (z1 - z5 zone) as shown in Fig. 1f. The results showed that the percentage of EdU-negative blastema cells in z1 zone was consistently higher than that in the z2-z5 zone on day 8, 10, 12 and 14 post-autotomy. In addition, we also observed the percentage of EdU-negative cells in z1 increased along with regeneration, with (78.1 ± 0.9) % on day 8, (82.5 ± 0.2) % on day 10, (88.9 ± 0.5) % on day 12 and (96.4 ± 0.6) % on day14 respectively. Lower proliferative cell populations are underneath epidermal basal cells in the distal-most blastema. a Schematic timeline for EdU injection and sample collection. One color indicated one timepoint. b–e’ EdU labeled proliferative cells on days 8, 10, 12, and 14 post-tail autotomy. The region between the solid and dotted lines denotes the WE. Arrowheads indicate EdU-negative blastema cells, while arrows indicate EdU-positive blastema cells. Enlarged views of the dashed line boxed areas in panels b, c, d, and e are shown in b’, c’, d’, and e’, respectively. Scale bars represent 500 µm (b-e) and 125 µm (b’-e’). f Statistical analysis of the percentage of EdU-negative blastema cells in every 50 µm zones from the distal-most end to the proximal side (z1 - z5) on day 8, 10, 12 and 14. z1 represents distal-most 50 µm area of blastema. The results showed that the percentage of EdU-negative blastema cells in z1 zone increased by 5.6% on day 10, 13.9% on day 12, and 23.5% on day 14 compared to that on day 8. The percentage of EdU-negative blastema cells in z1 zone was consistently higher than that in the z2-z5 zone on day 14. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± standard error of the mean (SEM), n = 5 biologically independent samples for each time point, The P values are shown on the panel. EdU, 5-ethynyl-2’-deoxyuridine; WE, wound epithelium. Our previous study demonstrated that Wnt/β-catenin pathway activation is essential for tail regeneration, with Wnt6 and Wnt10A mRNA levels being higher in the WE compared to the blastema during regeneration34. The Wnt/β-catenin pathway activation involves nuclear translocation of β-catenin35. To further investigated the situation of β-catenin localization in EdU-positive or EdU-negative blastema cells, we analyzed that in blastema cells within the most distal area of 150 µm on day 8, 10, 12 and 14 post-autotomy using immunofluorescence staining. The results revealed that the percentage of nuclear β-catenin cells in EdU-negative blastema cells was significantly higher than that in EdU-positive cells on day 10, 12 or 14. Moreover, compared to day 8, the percentage of nuclear β-catenin positive cells in EdU-negative blastema cells increased to 1.25-, 1.48- and 2.14-fold on days 10, 12 and 14, respectively (Fig. 2). These results suggest that Wnt/β-catenin signaling is activated in the lower proliferative distal blastema cells, paralleling its role in zebrafish fin regeneration. Collectively, the results highlight the conserved function of Wnt/β-catenin signaling in tissue regeneration, where it likely regulates the behavior of blastema cells underneath wound epithelium, either directly or indirectly. EdU-negative cells show more nuclear localized β-catenin than EdU-positive cells. a Representative immunofluorescence images showed β-catenin and EdU localization patterns on days 8, 10, 12 and 14 post-autotomy. Enlarged views of the left dashed boxed areas are shown in the right panels. The region between the solid and dotted lines indicates the WE. Arrowheads indicated nuclear β-catenin localization in EdU-negative blastema cells. Scale bars represent 40 µm (left) and 10 µm (right pabels, enlarged views). b Percentage of cells with nuclear β-catenin localization in EdU-positive or EdU-negative blastema cells. The cells within the most distal 150 µm area of blastema on days 8, 10, 12 and 14 post-autotomy were compared. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 5. The P values are shown on the panel. EdU, 5-ethynyl-2’-deoxyuridine; WE, wound epithelium. The proliferation of cultured blastema cell is reduced after activation of Wnt/β-catenin signaling via down-regulating FGFR4 expression Our previous results demonstrated that β-catenin was predominantly localized in the nucleus of EdU-negative cells in the distal blastema. In vitro assay also showed that canonical Wnt signaling was inactive in cultured blastema cells, whereas treatment with the Wnt activator SKL2001 induced nuclear translocation of β-catenin in these cells34. To further elucidate the role of Wnt/β-catenin signaling in cell proliferation, an EdU labeling assay was conducted to evaluate the proliferation of cultured blastema cells with activated Wnt/β-catenin signaling. The EdU labeling results showed that Wnt agonist SKL2001 treatment reduced the percentage of EdU-positive cells in cultured blastema cells. (Fig. 3). Proliferation of the cultured blastema cells is reduced following Wnt signaling activation. a EdU signals (red)of proliferating cells after 12 h and 24 h of SKL2001 (40 µM) treatment. Scale bar represents 75 µm. b Quantification of EdU-positive cells. The data showed that proliferation of cultured blastema cells was decreased by 37.8% at 12 h and 55% at 24 h following treatment with SKL2001. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 6. The P values are shown on the panel. NC negative control. To elucidate the mechanisms via which Wnt/β-catenin signaling influences cell proliferation, RNA-seq analysis was performed on cultured blastema cells treated with SKL2001 to assess global transcriptome changes. Both RNA-seq and qRT-PCR results indicated a significant downregulation of fgfr4 mRNA following Wnt signaling activation (Supplementary Fig. 1, Fig. 4a). To verify the negative regulation of FGFR4 expression by Wnt signaling during tail regeneration, immunofluorescent staining and qRT-PCR (tissues from 1 mm tip portion of the distal blastema) were utilized to examine the expression pattern of FGFR4. qRT-PCR results showed that the mRNA levels of fgfr4 on day 10 and 12 were lower than that on day 8 (Fig. 4b). Immunofluorescent staining and EdU labeling results showed that FGFR4 expression in z1 was lower than that in z3 and z4 (Fig. 4c, d). Meanwhile, few EdU signals were observed in z1 zone, which showed positive correlation between FGFR4 expression and cell proliferation. To further confirm the downregulation of FGFR4 by Wnt signaling, IWP-4, a Wnt/β-catenin inhibitor, was injected intraperitoneally starting on day 3 post-autotomy (Fig. 4e). The results of qRT-PCR revealed a 67.2% increase in fgfr4 expression on day 12 post-autotomy in the IWP-4 treatment group compared to controls (Fig. 4f), confirming that Wnt signaling activation reduces FGFR4 expression during tail regeneration. Wnt signaling activation reduces FGFR4 expression during tail regeneration. a qRT-PCR results showed that SKL2001 treatment reduced fgfr4 mRNA levels by 31.4% in cultured blastema cells. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. b qRT-PCR analysis of fgfr4 mRNA levels in the 1 mm tip portion of the distal blastema on days 8, 10, 12, 14 post-autotomy. Data were analyzed using one-way ANOVA followed by Dunnett’s post hoc test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. c Representative immunofluorescence and EdU staining images showed FGFR4 (green) expression and proliferating cells (EdU, violet) in regenerated tissues on days 8, 10, 12, and 14 post-autotomy. The region between the solid and dotted lines represent WE. Scale bars represent 50 µm. d Normalized FGFR4 fluorescence intensity of z1-z5 on day 14. Integrated density was divided by the corresponding cell area and expressed as fluorescence intensity per unit area (arbitrary units, a. u.). The mean value of the control group was set to 1. Data were analyzed using one-way ANOVA followed by Dunnett’s post hoc test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. e Schematic timeline for DMSO/IWP4 injection and sample collection. f qRT-PCR results showed a 67.2% increase in the mRNA levels of fgfr4 in the blastema after Wnt/β-catenin inhibition. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. WE, wound epithelium. NC, negative control. qRT-PCR, quantitative reverse transcription. Additionally, to demonstrate the effect of FGFR4 knockdown on tail regeneration and blastema cell proliferation. We intraperitoneally administered FGFR4 specific inhibitor BLU9931 and observed whether tail regeneration was affected. On day 8, in control (DMSO) group, 2 were in stage I and 11 were progressed in stage II, while in BLU9931 group, 9 were in stage I and 4 were in stage II. On day 12, in control (DMSO) group, 3 were in stage II and 10 were in stage Ⅲ, while in BLU9931 group, 4 were in stage I, 7 were in stage II and 2 were in stage Ⅲ. The results showed that BLU9931 treatment significantly delayed tail regeneration (Fig. 5a, b). The EdU labeling assay revealed that BLU9931 decreased proliferation by 56.6% in wound epithelium cells and 46.4% in blastema cells (Fig. 5c, d). Moreover, in vitro cultured blastema cells, fgfr4 knockdown led to a 49.8% decrease in the blastema cell proliferation compared to the control group (Supplementary Fig. 2). We further treated cultured blastema cells with Wnt agonist SKL2001 together with fgfr4 over-expression, the results revealed that fgfr4 over-expression alleviates the inhibitory effect of Wnt signaling on blastema cell proliferation (Fig. 5e, f). Collectively, these results suggest that Wnt/β-catenin signaling may reduce blastema cell proliferation by negatively regulating FGFR4 expression. FGFR4 inhibition delays tail regeneration and decreases blastema cell proliferation. a Schematic timeline for DMSO/BLU9931 injection and sample collection. b The regeneration stage were observed on days 8 and 12 post-autotomy. The results of statistical analysis showed that FGFR4 inhibitor BLU9931 delayed tail regeneration. Data were analyzed by χ2 test. The P values are shown on the panel. c EdU staining (red) of proliferating cells in DMSO group and BLU9931-treatment group. d Quantification of EdU-positive cells in WE and blastema. In DMSO group, the percentage of EdU-positive cells in WE = (56.9 ± 3.5) %, blastema = (48.3 ± 4.2) %. In BLU9931 group, the percentage of EdU-positive cells in WE = (24.7 ± 2.5) %, blastema = (25.9 ± 3.2) %. The results indicated that BLU9931 treatment suppressed cell proliferation in both wound epithelium and the blastema. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 5. The P values are shown on the panel. e, f EdU assay of proliferating cells after treatment with Wnt agonist SKL2001 combined with fgfr4 over-expression (OE-fgfr4) in vitro and quantification of EdU-positive cells showed that fgfr4 over-expression alleviated the inhibitory effect of Wnt signaling on cell proliferation. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 5, The P values are shown on the panel. WE, wound epithelium. Wnt/β-catenin signaling-activated blastema cells promote the migration of un-activated blastema cells without affecting their proliferation Wnt signaling was found to inhibit the proliferation of distal mesenchymal cells in the regenerated blastema, suggesting that these cells function as organizing centers that regulate the behavior of adjacent tissues. This prompted further investigation into the influence of Wnt-activated blastema cells on neighboring, untreated blastema cells. An in vitro co-culture system was established, where Wnt-activated blastema cells, treated with SKL2001, were cultured in the upper chamber, while untreated blastema cells were placed in the lower chamber to assess their proliferation. In contrast, to evaluate the migration of untreated cells in the presence of Wnt-activated cells, blastema cells treated with SKL2001 were cultured in the lower chamber (Fig. 6a). EdU labeling and transwell assay results revealed that Wnt-activated blastema cells induced migration of untreated blastema cells without impacting their proliferation (Fig. 6b-e). However, the underlying mechanism via which Wnt signaling modulates blastema cell behavior remains unclear. Wnt/β-catenin signaling-activated blastema cells promote migration of unactivated blastema cells. a Schematic of the co-culture system. b EdU signal (red) of proliferating cells in the co-culture proliferation system after 12 h and 24 h. Blastema cells treated with SKL2001 were cultured in the upper chamber, while untreated cells were cultured in the lower chamber. Red represents EdU, blue color indicates nucleus. Scale bar represents 75 µm. c Quantification of EdU-positive cells indicated that Wnt-activated cells did not affect the proliferation of unactivated cells. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 6, The P values are shown on the panel. d Co-culture transwell migration assay, where blastema cells treated with SKL2001 were cultured in the lower chamber and untreated cells in the upper chamber. Blue cells represent the cells that migrated to the lower surface of the upper chamber. Scale bar represents 75 µm. e Quantification of migrating cells showed that Wnt-activated cells led to a 79.7% increase in the migration of un-activated cells. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 6. The P value is shown on the panel. NC negative control. Wnt/β-catenin signaling activation induces FGF20 expression in distal blastema cells To elucidate the mechanisms via which Wnt-activated cells facilitate the migration of neighboring blastema cells, global transcriptomic changes in blastema cells treated with SKL2001 were analyzed via RNA-seq. RNA-seq and qRT-PCR results both revealed a significant up-regulation of fgf20 mRNA level in SKL2001-treatment blastema cell in vitro (Supplementary Fig. 1, Fig. 7a). FGF20, a key factor for fin regeneration, has been identified as a downstream target of β-catenin27,36,37. Wnt- targeted genes are activated by β-catenin interacting with the TCF/LEF transcription factor family38. Subsequently, the promoter sequence of the gecko fgf20 gene was retrieved to identify potential LEF1 binding sites using the JASPAR and AnimalTFDB v4.0 database (Fig. 7b). Luciferase reporter assays confirmed that β-catenin significantly upregulates fgf20 transcription (Fig. 7c), consistent with findings in other regeneration models. Wnt/β-catenin signaling upregulates FGF20 expression. a qRT-PCR results showed that fgf20 mRNA levels were increased by 4.32-fold after SKL2001 treatment in cultured blastema cells. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. b Prediction of potential binding sites for TCF/LEF-1 in the fgf20 promoter region using JASPAR and AnimalTFDB v4.0. c Luciferase reporter assay showed that β-catenin significantly enhanced fgf20 promoter activity. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 5, The P value is shown on the panel. d Immunofluorescence analysis of FGF20 expression in regenerated tissues on days 8, 10, 12 and 14 post-autotomy. The region between the solid and dotted lines represents the WE. Enlarged views of dashed boxed areas are shown in the bottom panel. Scale bars represent 200 µm (top panel) and 50 µm (bottom panel). The region between the solid and dotted lines represent the WE. e qRT-PCR analysis of relative mRNA levels of fgf20 on day 8, 10, 12 and 14 post-autotomy. The fgf20 mRNA level on day 8 was normalized as 1, and (day 10) = 1.96 ± 0.43, (day 12) = 3.59 ± 0.29, (day 14) = 9.17 ± 0.71. f qRT-PCR results showed an 83.8% decrease in the mRNA levels of fgf20 in the blastema on day 12 after Wnt/β-catenin inhibition. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 5. The P value is shown on the panel. NC negative control. qRT-PCR quantitative reverse transcription. WE wound epithelium. To validate the positive regulation of FGF20 expression by Wnt signaling during gecko tail regeneration, we evaluated FGF20 expression in blastema at different timepoints, and that on day 12 after IPW4 treatment using immunofluorescent staining and qRT-PCR (tissues from 1 mm tip portion of the distal blastema). Immunofluorescent staining results showed an obvious expression of FGF20 in the distal-most blastema adjacent to the wound epithelium, but not within the wound epithelium (Fig. 7d). Additionally, qRT-PCR results showed that the mRNA levels of fgf20 were gradually upregulated from day 8 to 14 post-autotomy (Fig. 7e). qRT-PCR results revealed that fgf20 expression on day 12 were significantly reduced following Wnt pathway inhibition compared to controls (Fig. 7f). These results confirm that Wnt signaling is essential for FGF20 expression during tail regeneration. To further investigate the role of FGF20 derived from Wnt-activated blastema cells, co-culture experiments were conducted with fgf20-overexpressing and untreated blastema cells (Fig. 8a). EdU labeling and transwell assay results showed that fgf20-overexpressing blastema cells led to a 2.47-fold increase in the migration of untreated blastema cells without affecting their proliferation in the co-culture system (Fig. 8b-e). To determine whether Wnt signaling regulates cell migration via FGF20, the effect of fgf20 knockdown on Wnt signaling induced migratory was examined. After knocking down fgf20 in Wnt/β-catenin-activated blastema cells, these cells were co-cultured with untreated blastema cells, the results revealed that fgf20 knockdown significantly reduced cell migration compared to the control and SKL2001-treated groups (Fig. 8f, g). These results provide further evidence that Wnt/β-catenin signaling-activated blastema cells promote migration of neighboring blastema cells through FGF20 secretion. Wnt signaling-activated blastema cells promote migration of unactivated blastema cells via FGF20. a Schematic of the co-culture system. b EdU signal of proliferating cells in the co-culture proliferation system. fgf20-overexpressing blastema cells were cultured in the upper chamber, while untreated cells were cultured in the lower chamber. c Quantification of EdU-positive cells showed that fgf20-overexpressing cells do not affect the proliferation of unactivated cells. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 6, The P value is shown on the panel. d Co-culture transwell migration assay, where fgf20-overexpressing blastema cells were cultured in the lower chamber, and untreated cells were cultured in the upper chamber. e Quantification of migrating cells showed that fgf20-overexpressing cells led to a 2.47-fold increase in the migration of unactivated cells. Data were analyzed using an unpaired Student’s t-test and are presented as mean ± SEM, n = 6, The P value is shown on the panel. f Co-culture transwell migration assay. The blastema cells were cultured in upper chamber and fgf20 knockdown blastema cells, in the presence or absence of SKL2001, cultured in the lower chamber. Scale bar represents 75 µm (b, d, f). g Quantification of migration showed that fgf20 knockdown significantly reduced migration of untreated blastema cells and attenuated the promotive effect of Wnt signaling on cell migration. Data were analyzed using two-way ANOVA followed by Bonferroni’s post hoc test and are presented as mean ± SEM, n = 5, The P values are shown on the panel. Discussion Wnt/β-catenin signaling is a highly conserved pathway in both mammals and non-mammalian vertebrates, playing essential roles in various biological processes, such as embryonic development, organogenesis, and regeneration39–41. During appendage regeneration, amputation-induced inflammation and ROS could modulate Wnt activation42,43. In zebrafish fin regeneration, Wnt/β-catenin signaling-activated cells may serve as signaling centers that regulate the regenerative process22. Our previous study demonstrated that inhibition of Wnt/β-catenin signaling impairs WE formation and tail regeneration in geckos, with Wnt ligands primarily expressed in the WE24. In this study, a reduction in the proliferation of blastema cells was observed upon Wnt signaling activation. Specifically, epidermal Wnt signaling decreased the proliferation rate of distal blastema cells adjacent to the WE, potentially through the downregulation of FGFR4 in Wnt-responsive cells. Moreover, Wnt-responsive blastema cells secreted FGF20, which subsequently regulated the migration of proximal blastema cells. The Wnt/FGF20 axis is a well-documented signaling pathway essential for epimorphic regeneration in many species28,44–46. Our study further confirms the conserved role of this signaling axis in the gecko, a terrestrial amniote model capable of regenerating its entire tail after autotomy. Across various regeneration-competent models, several key events are observed, including the distal distribution of FGF20 in the regenerated blastema and the reduced proliferation rate of blastema cells in these regions. However, the precise mechanisms underlying these effects are not yet fully understood. In this study, an in vitro co-culture system was designed to directly investigate the impact of Wnt agonists on blastema cells and the effect of Wnt-activated cells on normal blastema cells. Our results clearly demonstrated that FGF20, a factor secreted by Wnt-activated blastema cells, orchestrates the migration of blastema cells, providing positional cues that help establish the correct pattern of regenerated tissue. Furthermore, Wnt agonists reduced the proliferation of cultured blastema cells, with FGFR4 potentially serving as a target of this effect. These findings outline a signaling network within the regenerated tissues. The WE secrete Wnt ligands that induce the distal blastema cells adjacent to the epidermis to function as an organizing center for regeneration, exhibiting low proliferation rates while secreting various factors that modulate the migration of proximal blastema cells or the maturation of epidermal cells29. It is hypothesized that successful epimorphic regeneration requires precise and reciprocal communication between epidermal and mesenchymal tissues, which may be critical for organ and tissue regeneration in mammals. Although our results provide clear evidence for the role of the Wnt/FGF20 signaling axis in tail regeneration in geckos, the underlying effects and mechanisms should be further validated in vivo. For instance, knockout or knockdown of FGF20 in vivo could help to elucidate how FGF20 specifically influences the distance, direction, or both aspects of blastema cell migration. However, due to the challenges associated with genetic manipulation in geckos, such data are absent in our study. Consequently, developing reliable genetic manipulation techniques that enable gene knockout or lineage tracing of specific cell populations during tail regeneration in geckos remains a significant challenge. Recently, Wnt signaling was identified as a common initial response to injury signals in both the mouse and axolotl models47,48. The use of Wnt ligands at amputated sites is promising method to improve mammalian limb regeneration47,48. In the mouse digit tip regeneration, epidermal-derived Wnt promote mesenchymal cells growth. The function of Wnt is the key mechanism that coordinates regeneration of epithelial and mesenchymal tissues in mammalian digit-tip regeneration49,50. Our study provides insights into the cross-talk between mesenchymal and epidermal cells, which could inform the development of effective approaches for successful regeneration in mammals. In conclusion, as illustrated in Fig. 9, this study revealed the conserved role of the Wnt/FGF20 axis in the initiation of regeneration in geckos. Moreover, the role of FGF20 derived from distal-most mesenchymal cells, in promoting the migration of adjacent mesenchymal cells was identified. Our study also demonstrates that Wnt signaling-mediated downregulation of FGFR4 in blastema cells may contribute to the reduced proliferation of distal mesenchymal cells underneath the WE. These signals position the Wnt-activated distal blastema cells as an organizing center, coordinating the behavior of epidermal and mesenchymal cells during tail regeneration in geckos. Schematic representation of working model. Wnt signaling is activated in the distal blastema cells, leading to a reduction in the proliferation of distal blastema cells adjacent to the wound epithelium through the downregulation of FGFR4. Additionally, FGF20, induced by Wnt signaling, promotes the migration of proximal blastema cells. Methods Animal experiment All experimental protocols were approved by the Laboratory Animal Care and Use Committee of Nantong University (Animal Protocol: S20210312-009). We have complied with all relevant ethical regulations for animal use. Gekko japonicus with intact tails, aged 15 to 17 months and weighing an average of 4.3 ± 0.4 g, were obtained from the Animal Center of Nantong University. The geckos were housed in a controlled environment at 28 °C and provided with mealworms and sterilized water for sustenance. Animals were randomly assigned to groups with an equal sex distribution (50% male, 50% female). Following established protocols24, tail autotomy was induced by placing a nylon slipknot around tail segment 6 and gently pulling, simulating natural autotomy. Successful regeneration was indicated by the shedding of scabs and the appearance of the pink WE on day 7. The early periods of regeneration were categorized into three stages: Stage I, Stage II and Stage III24. The Wnt inhibitor IWP-4 (2 mg/kg body weight, Cat# E0033, Selleck Chemicals, Houston, TX) or FGFR4 specific inhibitor BLU9931 (100 mg/ kg body weight, Cat# HY-12823, MedChemExpress, Monmouth Junction, NJ, USA) dissolved in 5% dimethylsulphoxide (DMSO) saline solution was injected intraperitoneally every other day from day 3 post-autotomy. Control experiments were performed according to the same protocol with an equivalent amount of vehicle. 25 μl of 10 mM EdU (Cat# C0212, Beyotime Biotechnology, Shanghai, China) diluted in phosphate-buffered saline (PBS) were injected intraperitoneally for two days prior to sample collection. In Wnt signaling inhibition experiment, 10 geckos were in both the control and IWP-4 groups. In FGFR4 inhibition experiment, 26 geckos were in the control and BLU9931 groups. The geckos were housed in plastic containers measuring 22.5 cm (length) × 15 cm (width) × 12 cm (height), with five individuals per container, inside a 28 °C incubator. The periods of the geckos were assessed daily between 17:00 and 18:00. Geckos were anesthetized on ice and disinfected with 75% alcohol. The blastema, located 0.5 cm proximal to the injury site, was fixed overnight in 4% paraformaldehyde at 4 °C, then dehydrated in a sucrose gradient (10%, 20%, 30%) and embedded in optimal cutting temperature (OCT) compound (Cat# RE202002, Tuoran Bio, China). Sections of 12 μm thickness were prepared. Culture and treatment of blastema cell For cell isolation at 12 days post-autotomy, the blastema tissue was sterilized with 75% EtOH, cut into pieces, and digested with collagenase I (Cat# C8140, Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) at 30 °C for 10 minutes, followed by digestion in 0.25% trypsin (Cat# 25200072, Gibco, Grand Island, NY, USA) for an additional 10 minutes at 30 °C. Digestion was halted with DMEM/F12 containing 10% FBS (Fetal Bovine Serum, Cat# 04-001-1-CS, Biological Industries, Beit-HaEmek, Israel), 2 mM glutamine (Cat# C0212, Beyotime), and penicillin-streptomycin-amphotericin solution (Cat# C0222, Beyotime). Cells were collected by centrifugation for 5 minutes, resuspended, and passaged. Passage 2 cells were used for subsequent assays. The cultured cells were treated with the Wnt/β-catenin signaling agonist SKL200134 (40 μM, Cat# S8320, Selleck Chemicals) for 24 hours prior to assays. Small interfering RNA (siRNA) and plasmids transfection Blastema cells were seeded into 6-well plates at an initial density of 1.5 × 105 cells/well. For siRNA transfection, 30 nM siRNA was delivered into the cells using Lipofectamine RNAiMAX (Cat# 13778075, ThermoFisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol. The siRNAs, including the negative control (si-Ctrl), fgf20-specific siRNA (si-fgf20) and fgfr4-specific siRNA (si-fgfr4), were synthesized by GenePharma (Suzhou, China), with sequences provided in Table 1. The plasmids used in this study were pCI-neo, pCI-neo- fgf20 and pCI-neo-fgfr4 were all purchased from Anhui General Biology Co., Ltd. For plasmid transfection, 2.5 μg of DNA was introduced into cells using Lipofectamine 8000 reagent was used. After transfection, cells were cultured for 24 hours. Table 1The sequences of the primers and siRNAs used in the studyNameSense (5’ - 3’)Antisense (5’ - 3’)Control (Ctrl) siRNAuucuccgaacgugucacguttacgugacacguucggagaattfgf20 siRNAgaagagaacugguacaacattuguuguaccaguucucuucttfgfr4 siRNAgccucauaaucacaugguattuaccaugugauuaugaggcttef1αgatggaaagtgacccgcagaggaagacgcagaggtttgfgf20tggcagtgggtttagtcagacattggaggagtaagtgttgtfgfr4gaggttccccatatccaggtccctccaccagttgcttaaa The sequences of the primers and siRNAs used in the study Immunofluorescence assay Tissue sections were washed in PBS, permeabilized with 0.5% Triton X-100, and blocked with 10% goat serum. Sections were incubated overnight at 4 °C with rabbit anti-β-catenin (1:200, Cat# ab32572, Abcam, Cambridge, UK), rat anti-FGF20 antibody (1:50, Cat# MA5-23972, Thermo Fisher Scientific) and rabbit anti-FGFR4 (1:50, Cat#11098-1-AP, Proteintech, Wuhan, China). Following washing in 0.01 M PBS, the sections were incubated with Alexa Fluor® 488-conjugated secondary antibodies: Goat Anti-Rabbit IgG (H + L) (1:400, Cat# 111-545-003, Jackson ImmunoResearch Labs) and Goat Anti-Rat IgG (H + L) (1:400, Cat# 112-545-167, Jackson ImmunoResearch Labs) at room temperature for 2 hours. Nuclei were stained with DAPI (Cat# 0100-20, SouthernBiotech). Images were captured using a Zeiss Axio Imager M2 fluorescence microscope (Carl Zeiss Microscopy GmbH, Jena, Germany) and analyzed with ImageJ software. The integrated density of each zone (z1-z5) on day 14 was measured and divided by the corresponding cell area, expressing as fluorescence intensity per unit area (arbitrary units, a. u.). The mean value of the control group was set to 1. EdU proliferation assay Cell proliferation was assessed using the BeyoClickTM EdU Cell Proliferation Kit with Alexa Fluor 594 (Cat# C7008S, Beyotime), following the manufacturer’s protocol. Briefly, cells or tissue sections were washed in PBS, permeabilized with 0.3% Triton X-100, and treated with a click reaction solution. Nuclei were stained with DAPI, and signals were visualized using a Leica DMi8 microscope (Leica Microsystems CMS GmbH, Wetzlar, Germany). The number of EdU-positive cells was quantified using ImageJ, and the proliferation rate was calculated as the ratio of EdU-positive cells to the total cell count. RNA sequencing and bioinformatic analysis Total RNA from cultured blastema cells was extracted using TRIzol Reagent (Vazyme, Nanjing, China). The concentration and purity of total RNA were assessed with a NanoDrop 2000 spectrophotometer (Thermo Scientific). Libraries were constructed using the NEBNext Ultra II RNA Library Prep Kit for Illumina (New England Biolabs, Ipswich, Massachusetts, USA) according to the manufacturer’s instructions. Briefly, mRNA was purified with poly-T oligo-attached magnetic beads. RNA fragmentation was achieved using divalent cations at elevated temperatures in an Illumina proprietary fragmentation buffer. First strand cDNA was synthesized with random oligonucleotide primers and Super Script II. Second strand cDNA synthesis was generated with DNA Polymerase I and RNase H. After end-repaired and 3′-adenylated, Illumina paired-end adapters were ligated. cDNA fragments of 400–500 bp were selected by AMPure XP system (Beckman Coulter, Beverly, CA, USA), amplified for 15 cycles with Illumina PCR Primer Cocktail. Products were purified (AMPure XP system) and quantified using the Agilent High Sensitivity DNA Assay on a Bioanalyzer 2100 system (Agilent). Sequencing was performed on the NovaSeq 6000 platform (Illumina) at Shanghai Personal Biotechnology Co., Ltd. Expression analysis was carried out with HTSeq (v0.9.1), generating raw read counts for each gene. These counts were normalized using FPKM. Differential expression analysis was performed with DESeq (v1.38.3) with a threshold of p < 0.05 and fold-change > 2. Real-time quantitative PCR For RNA extraction from regenerated tails, total RNA was isolated using TRIzol (Vazyme, Nanjing, China), quantified, and reverse transcribed with the HiScript III 1st Strand cDNA Synthesis Kit (Cat# R312-02, Vazyme). Quantitative real-time polymerase chain reaction (qRT-PCR) was conducted with Taq Pro Universal SYBR qPCR Master Mix (Cat# Q712, Vazyme) on a SqTOWER3 Real-Time PCR System (Analytik Jena). Data were normalized to the endogenous ef1α gene, and target gene expression levels were calculated using the 2−ΔΔCt method. Primer sequences are listed in Table 1. Transwell assay For migration assays, untreated blastema cells were suspended and seeded into the upper chamber of a 6.5 mm Transwell with 8 μm pores (Cat# 3422, Costar) at a density of 1 × 104 cells/well. Blastema cells treated with SKL2001 (40 μM) or overexpressing fgf20 were seeded into the lower chamber at a density of 8 × 104 cells/well. After 24 hours, the upper chamber was removed, fixed in 4% PFA for 15 minutes, and washed with PBS. The upper surface of the chamber was cleaned with a cotton swab, and the cells that migrated to the lower surface were stained with 0.1% crystal violet for 20 minutes. Migrating cells were visualized using a Leica DMi8 microscope (Leica Microsystems) and quantified using ImageJ. Luciferase reporter assay HEK-293T cells (ATCC) were cultured in high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM; Cat# MA0212, Meilunbio, Dalian, China) supplemented with 10% FBS, 1% penicillin (100 U/ml), and 100 μg/ml streptomycin in a 5% CO2 humidified atmosphere at 37 °C. For promoter analysis, the 1 kb region upstream of the transcription start site of the gecko fgf20 gene was analyzed using JASPAR and AnimalTFDB v4.0. The coding sequence (CDS) of the β-catenin gene was cloned into the pCI-neo vector, resulting in pCI-neo-β-catenin. The promoter region from -2000 to +1 bp of the fgf20 gene was cloned into the pGL4.10 vector, resulting in pGL4.10-fgf20. pGL4.10-fgf20 was co-transfected with pCI-neo-β-catenin or the empty pCI-neo vector into HEK-293T cells. Luciferase reporter assays were performed 48 hours post-transfection, and luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Cat# E1910, Promega, Madison, WI, USA) according to the manufacturer’s instructions. Relative luciferase activity was normalized to Renilla luciferase activity. Statistics and reproducibility Each experiment was performed at least five times and sample size was qualified according to methodology and was specialized in figure legends. Statistical analysis was conducted using GraphPad Prism 8.3.0. Data are presented as mean ± standard error of the mean (SEM). Normality was assessed using the Shapiro-Wilk test, and homogeneity of variances was verified with Brown-Forsythe test. Unpaired two-tailed Student’s t-test was used to compare two groups. One-way ANOVA with Dunnett’s post hoc test was performed for comparison between one control group and all other groups. We applied two-way ANOVA with Bonferroni’s post hoc test to analyze the data affected by the two factors. Chi-square test was adopted in the analysis for regeneration rate. P < 0.05 was considered statistically significant. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Transparent Peer Review file Supplementary information Description of Additional Supplementary Files Supplementary Data 1 reporting summary Acknowledgements This work was supported by National Natural Science Foundation of China (Grant No.32100380, 32471038, 31970412). Author contributions Yan Liu, Man Xu and Mei Liu conceptualized the project. Yan Liu, Man Xu, Zhen Li and Mingxuan Li designed experiments. Man Xu, Zhen Li, Mingxuan Li, Jing Yu., Shuai Huang, Yanran Xu, Yufang Zhang, Xu Chen, Ronghua Wu and Mei Liu performed experiments and analyses. Man Xu, Yan Liu wrote the paper and all authors were involved in the editing process. Yan Liu and Man Xu acquired funding. Peer review Peer review information Communications Biology thanks Wouter Masselink and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Simona Chera, David Favero and Johannes Stortz. [A peer review file is available]. Data availability All data are contained within the manuscript and Supplementary Data files. RNA sequencing data used/analyzed in this study have been deposited into the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/) (GSE309950). The source data for graphs are provided in the Supplementary Data 1. Additional data are available from the corresponding author upon reasonable request. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Man Xu, Zhen Li. Contributor Information Mei Liu, Email: liumei@ntu.edu.cn. Yan Liu, Email: liuyan@ntu.edu.cn. Supplementary information The online version contains supplementary material available at 10.1038/s42003-025-09360-6. References Associated Data Supplementary Materials Transparent Peer Review file Supplementary information Description of Additional Supplementary Files Supplementary Data 1 reporting summary Data Availability Statement All data are contained within the manuscript and Supplementary Data files. RNA sequencing data used/analyzed in this study have been deposited into the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/) (GSE309950). The source data for graphs are provided in the Supplementary Data 1. Additional data are available from the corresponding author upon reasonable request.